溃疡性结肠炎大鼠结肠粘膜肥大细胞类胰蛋白酶表达变化及其抑制剂的作用
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
背景:葡聚糖硫酸钠(DSS)诱导的溃疡性结肠炎大鼠的组织学特点与人类溃疡结肠炎(Ulcerative Colitis, UC)类似。实验性溃疡性结肠炎和人溃疡性结肠炎肠粘膜内肥大细胞(Mast Cell,MC)的活性和数量显著增多,其中类胰蛋白酶(tryptase)是其活化和释放颗粒的特异性标志。
     目的:测定DSS诱导的溃疡性结肠炎大鼠结肠粘膜中MC数量和tryptase表达变化、及IL-6、IL-8的含量变化,并观察类胰蛋白酶抑制剂(tryptase inhibitor, TPI)对他们的影响。
     方法:40只雄性Wistar大鼠按1:3随机分为A组(空白对照组,10只)和S组(研究组,30只),A组自由饮用无菌蒸馏水7天,后续无菌蒸馏水连续灌肠7天,1次/天;S组自由饮用3%DSS溶液7天,然后再随机分为B组(模型对照组,无菌蒸馏水灌肠)、C组(NM组,10-9mol/L灌肠)、D组(5-ASA组,100mg/kg灌肠),每组10只。实验结束,对疾病活动指数(DAI)、组织学损伤指数(HI)、远端结肠组织肥大细胞(甲苯胺蓝改良染色法)和类胰蛋白酶的表达(免疫组化)进行评价,取血清测IL-6和IL-8(ELISA法)的浓度。
     结果:⑴治疗第1天,A组(空白对照组)DAI评分与B组(模型对照组)、C组(NM组)、D组(5-ASA组)相比,有显著统计学意义(P<0.01);实验结束后,B组DAI、HI评分(6.50±1.43、5.10±0.74)与C组(3.40±1.26、2.30±0.67)、D组(2.60±0.97、2.00±0.82)相比明显增高(P<0.01);⑵远端结肠粘膜肥大细胞数及类胰蛋白酶表达:B组(15.30±1.89,102.87±3.39)与C组(5.40±1.43,140.27±1.65)、D组(4.40±1.51,142.95±2.62)相比,表达显著增高(P<0.01);⑶血清IL-6、IL-8浓度比较:B组(72.81±12.64,234.29±18.56)比C组(41.39±4.82,140.68±9.38)、D组(37.21±8.29,138.81±15.83)浓度显著增高(P<0.01)。以上各指标C组(NM组)与D组(5-ASA组)比较无统计学差异(P>0.05)。
     结论:小剂量类胰蛋白酶抑制剂可以下调结肠粘膜肥大细胞数量、抑制肥大细胞类胰蛋白酶表达,对DSS诱导溃疡性结肠炎大鼠有治疗作用。
Background:
     Dextran sulfate sodium(DSS)-induced colitis mimics human Ulcerative Colitis (UC) in histological features. The activities and number of mast cell (MC) in colonic mucosa are significantly increased both in experimental colitis and UC patients. Tryptase is considered as a unique maker of MC’s activation.
     Aims:
     To investigate the number of MC and the expression of MC tryptase in the colonic mucosa in rat with DSS-induced ulcerative colitis, and the effects of the tryptase inhibitor (TPI) on the colitis.
     Methods:
     Forty male Wistar rats were randomly divided into two groups, group A (control group,10 rats) and group S (experimental group, 30 rats). Rats in group A were free to drink distilled water for 7 days and then received an enema once a day for a continual 7 days; Rats in group S were given 3% DSS solution for 7 days and then randomly subdivided into 3 groups with an enema of three different solution once a day for a continual 7 days: Group B (distilled water), Group C ( NM, 10-9mol/L),and Group D(5-ASA, 100mg/kg). At the end of the procedure, the DAI and HI were caculated. The MC number and the expression of MC tryptase in the distal colonic mucosa were assessed by toluidine blue staining and immunohistochemistry respectively. The concentrations of IL-6 and IL-8 were assessed by ELISA.
     Result:
     ⑴On the first day after treatment, the DAI in groupB (distilled water) was significantly higher than that in group C ( NM) and D (5-ASA) respectively(P<0.01). While on the 7th day , the scores of DAI and HI in group B (6.50±1.43,5.10±0.74) were significant different from those in group C(3.40±1.26、2.30±0.67)and in group D(2.60±0.97、2.00±0.82)(P<0.01, respectively).⑵The number of mucosa mast cell and average gray scale (AGS) of MC tryptase in group B(15.30±1.89,102.87±3.39)showed significant difference when compared with those in group C(5.40±1.43,140.27±1.65)and in group D(4.40±1.51,142.95±2.62)( P<0.01 , respectively).⑶The levels of serum IL-6 and IL-8 in group B(72.81±12.64,234.29±18.56)were significant higher than those in group C(41.39±4.82,140.68±9.38)or in group D(37.21±8.29,138.81±15.83)(P<0.01, respectively). There was no significant difference among these indexes in group C and group D (P>0.05).
     Conclusions:
     A small dosage of tryptase inhibitor may downregulate the mast cell number and the tryptase expression in the colonic mucosa in rats with DSS-induced ulcerative colitis, which may has a beneficial effect on this disease.
引文
[1] Penissi AB, Rudolph MI, Piezzi RS.Role of mast cells in gastro-intestinal mucosal Defense. Biocell,2003,27(2):163-172.PMID: 14510234 [PubMed - indexed for MEDLINE]
    [2] Farhadi A, Fields JZ, Keshavarzian A.Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: Stress, intestinal hyperperme-ability and inflammation. World J Gastroenterol , 2007,13(22): 3027-3030. PMID: 17589915 [PubMed - indexed for MEDLINE]
    [3] Nolte H, Spjeldnaes N, Kruse A, Windelborg B. Histamine release from gut mast cells from patients with inflammatory bowel diseases. Gut ,1990,31(7): 791–794. PMID: 1695160 [PubMed - indexed for MEDLINE]
    [4] Wierzbicki M, Brzezińska-B?aszczyk E. The role of mast cells in the development of inflammatory bowel diseases. Postepy Hig Med Dosw (Online),2008,62:642-650. PMID: 19037190 [PubMed - indexed for MEDLINE]
    [5] Kawabata A, Matsunami M, Sekiguchi F.Gastrointestinal roles for proteinase- activated receptors in health and disease. British Journal of Pharmacology , 2008, 153(1): S230-S240. PMID: 17994114 [PubMed - indexed for MEDLINE]
    [6] Tremaine WJ,Brzezinski A, Katz JA, Wolf DC, Fleming TJ,Mordenti J, Strenkoski-Nix LC, Kurth MC; AXYS Ulcerative Colitis Study Group. Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study. Aliment Parmacol Ther, 2002,16(3):407-413. PMID: 11876693 [PubMed - indexed for MEDLINE]
    [7] Egger B,Bajai-Elliott M,MacDonald"IT, Inglin R, Eysselein VE, Büchler MW.Characterisation of acute murine dextran sodium sulphate colitis:cytokine profile and dose dependency.Digestion,2000,62(4):240-248.PMID: 11070407 [PubMed - indexed for MEDLINE]
    [8]张艳丽,黄循铷,王承党.小鼠葡聚糖硫酸钠急性溃疡性结肠炎模型的建立和评价.胃肠病学和肝病学杂志,2006,15(2):l30-l33.维普网
    [9] Isozaki Y, Yoshida N, Kuroda M, Handa O, Takagi T, Kokura S, Ichikawa H, Naito Y, Okanoue T, Yoshikawa T. Anti-tryptase treatment using nafamostat mesilatehas a therapeutic effect on experimental colitis. Scand J Gastroenterol, 2006,41(8): 944-953. PMID: 16803693 [PubMed - indexed for MEDLINE]
    [10]梅俏,于皆平,许建明,项立,魏伟,岳莉. MT对大鼠乙酸性结肠炎的影响及有关机制初探[N].中国药理学通报, 2002,18(2):172-174.万方数据库
    [11] Murano M, Maemura K, Hirata I, Toshina K, Nishikawa T, Hamamoto N, Sasaki S, Saitoh O, Katsu K.Therapeutic effect of intracolonically administered nuclear factor kappa B(p65)antisense oligonucleotide on mouse dextran sulphate sodium(DSS)- induced colitis.Clin Exp Immunol,2000,120(1):51-58.PMID: 10759763 [PubMed - indexed for MEDLINE]
    [12] Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pe?a AS, Meuwissen SG, Van Rees EP.Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Thl and Th2 cytokines.Clin Exp lmmunol,1998,114(3):385- 391.PMID: 9844047 [PubMed - indexed for MEDLINE]
    [13]陈萌,张冬梅,韦兰兰.枳实芍药散对大鼠肠道高敏性的影响.中国实验方剂学志,2007,13(6):49-52.万方数据
    [14] Gurudu S, Fiocchi C, Katz JA.Inflammatory bowel disease. Best Pract Res Clin Gastroenterol.2002,16(1): 77–90. PMID: 11977930 [PubMed - indexed for MEDLINE]
    [15] Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol,2003,3(7): 521–533. PMID: 12876555 [PubMed - indexed for MEDLINE]
    [16] Lakatos L. Immunology of inflammatory bowel diseases. Acta Physiol Hung.2002,87(4): 355–372. PMID 11732889[PubMed - indexed for MEDLINE]
    [17] Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol ,2006,41(1):10–16. PMID: 16501852 [PubMed - indexed for MEDLINE]
    [18] Podolsky DK. Inflammatory bowel disease. N Engl J Med ,2002, 347(6):417–29. PMID: 12167685 [PubMed - indexed for MEDLINE]
    [19] Rachmilewitz D, Karmeli F, Takabayashi K, Hayashi T, Leider-Trejo L, Lee J, Leoni LM, Raz E.Immunostimulatory DNA ameliorates experimental and spontaneousmurine colitis.Gastroenterology,2002,122(5):1428-41. PMID: 11984528 [PubMed - indexed for MEDLINE]
    [20] Ohkawara T, Nishihira J, Takeda H, Hige S, Kato M, Sugiyama T, Iwanaga T, Nakamura H, Mizue Y, Asaka M.AmeHorafion 0f dextran sulfate Sodium-induced colitis by anti-macrophase migration inhibitory factor antibody in mice. Gastroenterology,2002,123(1):256-270.PMID: 12105854 [PubMed - indexed for MEDLINE]
    [21] Forbes E,Murase T,Yang M,Matthaei KI, Lee JJ, Lee NA, Foster PS, Hogan SP.Immunopathogenasis of experimental ulcerative colitis is mediated by eosinophil peroxidase.J Immunol,2004,172(9):5664-5675.PMID: 15100311 [PubMed - indexed for MEDLINE]
    [22] Melgar S, Karlsson L, Rehnstr?m E, Karlsson A, Utkovic H, Jansson L, Micha?lsson E. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol, 2008, 8(6):836-844. PMID: 18442787 [PubMed - indexed for MEDLINE]
    [23] Papadakis KA, Targan SR. Current theories on the causes of inflammatory bowel disease. Gastroenterol Clin North Am, 1999,28(2): 283-296. PMID: 10372269 [PubMed - indexed for MEDLINE]
    [24] Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology, 1995,108(5):1566-1581. PMID: 7729650 [PubMed - indexed for MEDLINE]
    [25] Sarin SK, Malhotra V, Sen Gupta S, Karol A, Gaur SK, Anand BS. Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci,1987,32(4): 363-367. PMID: 2881741 [PubMed - indexed for MEDLINE]
    [26] Bischoff SC, Wedemeyer J, Herrmann A, Meier PN,Trautwein C, Cetin Y, Maschek H, Stolte M, Gebel M, Manns MP. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology, 1996;28(1): 1-13. PMID: 8838115 [PubMed - indexed for MEDLINE]
    [27] King T, Biddle W, Bhatia P, Moore J, Miner PB Jr. Colonic mucosal mast celldistribution at line of demarcation of active ulcerative colitis. Dig Dis Sci, 1992,37(4): 490-495. PMID: 1551335 [PubMed - indexed for MEDLINE]
    [28] Gelbmann CM, Mestermann S, Gross V,Kollinger M, Scholmerich J, Falk W. Strictures in Crohn’s disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut,1999,45(2): 210–7. PMID: 10403732 [PubMed - indexed for MEDLINE]
    [29] Araki Y, Andoh A, Fujiyama Y, Bamba T. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol ,2000,119(2): 264–269. PMID: 10632661 [PubMed - indexed for MEDLINE]
    [30] Dvorak AM, McLeod RS, Onderdonk A, Monahan-Earley RA, Cullen JB, Antonioli DA, Morgan E, Blair JE, Estrella P, Cisneros RL. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int Arch Allergy Immunol,1992,99(1): 74–83. PMID: 1483068 [PubMed - indexed for MEDLINE]
    [31] Miller HR, Pemberton AD.Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology , 2002, 105(4): 375–390. PMID: 11985658 [PubMed - indexed for MEDLINE]
    [32] Caughey GH. New developments in the genetics and activation of mast cell proteases. Mol Immunol,2002,38(16-18):1353–1357. PMID: 12217407 [PubMed - indexed for MEDLINE]
    [33] Schwartz LB, Lewis RA, Seldin D,Austen KF. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J Immunol,1981,126(4),1290–1294. PMID: 7009736 [PubMed - indexed for MEDLINE]
    [34] Abraham WM. Tryptase: potential role in air way inflammation and remodeling. Am J Physiol Lung Cell Mol Physiol,2002,282(2): L197–L206. PMID: 11792623 [PubMed - indexed for MEDLINE]
    [35] Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec AS & Metcalfe DD.The alpha form of human tryptase is the predominant type present in blood atbaseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest,1995,96(6) :2702–2710. PMID: 8675637 [PubMed - indexed for MEDLINE]
    [36] Wang HW, McNeil HP, Husain A, Liu K, Tedla N,Thomas PS, Raftery M, King GC, Cai ZY,Hunt JE.Delta tryptase is expressed in multiple human tissues, and a recombinant form has proteolytic activity.J Immunol,2002,169(9):5145–5152. PMID: 12391231 [PubMed - indexed for MEDLINE]
    [37] Raithel M, Winterkamp S, Pacurar A, Ulrich P, Hochberger J, Hahn EG. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand J Gastroenterol, 2001,36(2):174-179. PMID: 11252410 [PubMed - indexed for MEDLINE]
    [38] Cenac N, Coelho AM, Nguyen C, Compton S, Andrade-Gordon P, MacNaughton WK, Wallace JL, Hollenberg MD, Bunnett NW, Garcia-Villar R, Bueno L, Vergnolle N.Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol ,2002,161(5):1903-1915. PMID: 12414536 [PubMed - indexed for MEDLINE]
    [39] Hallgren J, Pejler G. Biology of mast cell tryptaseAn inflammatory mediator. The FEBS Journal , 2006,273(9), 1871–1895. PMID: 16640553 [PubMed - indexed for MEDLINE]
    [40] Hansen KK, Sherman PM, Cellars L, Andrade-Gordon P, Pan Z, Baruch A, Wallace JL, Hollenberg MD, Vergnolle N. A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis.Proceedings of the National Academy of the United States of America,2005,102(23):8363-8368. PMID: 15919826 [PubMed - indexed for MEDLINE]
    [41]窦勇鹰,谢立群,李俊美,华建平.蛋白酶激活受体的研究进展.世界华人消化杂志, 2006,14(12): 1206-1209.万方数据库
    [42] Ossovskaya VS,Bunnett NW.Protease-activated receptors: contribution to physiology and disease.Physiol Rev,2004,84(2):579–621. PMID: 15044683 [PubMed - indexed for MEDLINE]
    [43] He SH, Walls AF. Human mast cell tryptase:a stimulus of microvascular leakage and mast cell activation. Eur Pharmacol, 1997, 328(1): 89–97. PMID: 9203574 [PubMed - indexed for MEDLINE]
    [44] He SH, Peng Q, Walls AF. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: selective enhancement of eosinophil recruitment by histamine.J Immunol ,1997,159(12): 6216–6225. PMID: 9550425 [PubMed - indexed for MEDLINE]
    [45] Temkin V, Kantor B, Weg V, Hartman ML, Schaffer FL.Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J Immunol ,2002, 169(5): 2662-2669. PMID: 12193739 [PubMed - indexed for MEDLINE]
    [46] Kim JA, Choi SC, Yun KJ, Kim DK, Han MK, Seo GS, Yeom JJ, Kim TH, Nah YH, Lee YM. Expression of protease-activated receptor 2 in ulcerative colitis. Inflamm Bowel Dis ,2003,9(4): 224–229. PMID: 12902845 [PubMed - indexed for MEDLINE]
    [47] Shpacovitch V, Feld M, Hollenberg MD, Luger TA, Steinhoff M. Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. Journal of Leukocyte Biology ,2008,83(6):1309-1322. PMID: 18347074 [PubMed - indexed for MEDLINE]
    [48] Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, Hoshino T, Kubo M, Yamashita A, Okabe M, Takeda K, Akira S, Matsumoto S, Toyonaga A, Sata M, Yoshimura A. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med ,2001,193(4): 471-481. PMID: 11181699 [PubMed - indexed for MEDLINE]
    [49] Wang L, Walia B, Evans J, Gewirtz AT, Merlin D, Sitaraman SV.IL-6 induces NF-kappa B activation In the intestinal epithelia.J Immunol,2003,171(6):3194- 3201.PMID: 12960348 [PubMed - indexed for MEDLINE]
    [50]王为,周国华.细胞因子与炎症性肠病.临床军医志,2007,35(3):453-456.维普网
    [51]谢华,何韶衡,程明华,傅意玲.类糜蛋白酶抑制剂对人大肠肥大细胞类胰蛋白酶释放的影响.中国免疫学杂志,2005,21(9):701-709.维普网
    [52] Mori S, Itoh Y, Shinohata R, Sendo T, Oishi R, Nishibori M.Nafamostat mesilate is an extremely potent inhibitor of human tryptase. J Pharmacol Sci, 2003, 92(4):420-423. PMID: 12939527 [PubMed - indexed for MEDLINE]
    [53]张艳丽,王承党,余鸣秋.小鼠葡聚糖硫酸钠结肠炎模型结肠黏膜中5-羟色胺及其转运蛋白的变化和意义.胃肠病学,2007,12(6):353-356.维普网
    [54] Mousavizadeh K, Rahimian R, Fakhfouri G, Aslani FS, Ghafourifar P. Anti- inflammatory effects of 5-HT receptor antagonist,tropisetron on experimental colitis in rats. Eur J Clin Invest, 2009, [Epub ahead of print]. PMID: 19302562 [PubMed - as supplied by publisher]
    [1] Longstreth GF, Wilson A, Knight K, Wong J, et al. Irritable bowel syndrome, health care use, and costs (a U.S. managed care perspective). Am J Gastroenterol 2003;98(3):600–7. PMID: 12650794 [PubMed - indexed for MEDLINE]
    [2] RitehieJ.Pain from distention of the Pelvic colon by inflating a balloon in the irritable colon syndrome.Gut,1973,14(2):125-132. PMID: 4696535 [PubMed– indexed for MEDLINE]
    [3] Chang, L, Mayer EA, Johnson T, et al. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain ,2000,84(2-3): 297-307. PMID: 10666535 [PubMed - indexed for MEDLINE]
    [4] Fukudo S, Nomura T, Muranaka M, Taguchi F. Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J Clin Gastroenterol, 1993,17(2):133–141. PMID: 8031340 [PubMed - indexed forMEDLINE]
    [5]Fukudo S. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol ,2007, 42[Suppl XVII]:48–51. PMID 17238026 [PubMed - indexed for MEDLINE]
    [6] Accarino AM, Azpiroz F, Malagelada JR. Attention and distraction: effects on gut perception. Gastroenterology,1997,113(2): 415-422. PMID: 9247458 [PubMed– indexed for MEDLINE]
    [7] Bonaz B,Baciu M ,Pap illon E,et al.Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study .A m J Gastroenterol,2002,97(3): 654-661. PMID: 12749964 [PubMed - indexed for MEDLINE]
    [8] Bernstein CN , F rankenstein UN , Raw stho rne P, et al. Cortical mapping of visceral pain in patients with GI disorders using functional magnetic resonance imaging . A m J Gastroenterol, 2002,97(2):319-327. PMID: 11866268 [PubMed - indexed for MEDLINE]
    [9] Barbara G, De Giorgio R , Stanghellini V , et al . A role for inflammation in irritable bowel syndrome? Gut ,2002 ,51(Suppl 1):i41-44. PMID: 12077063 [PubMed - indexed for MEDLINE]
    [10] Baigent SM, Lowry PJ. mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRFbinding protein in peripheral rat tissues . J Mol Endocrinol,2000,25(1):43–52. PMID: 10915217 [PubMed– indexed for MEDLINE]
    [11] Liu S,Gao X,Gao N,et al.Expressionof type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system .J Comp Neurol,2005, 481 (3):284-298. PMID: 15593376 [PubMed - indexed for MEDLINE]
    [12] Shin F.Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation .Gastroenterol,2007,42(Suppl XVII):48–51.PMID: 17238026 [PubMed - indexed for MEDLINE]
    [13] Goyal RK, Hirano I. The enteric nervous system . The new England journal of medicine, 1996,334(17):1106-1115. PMID: 8598871 [PubMed - indexed for MEDLINE]
    [14] B?hmelt AH , Nater UM ,Franke S ,et al. Basal and Stimulated Hypothalamic- Pituitary-Adrenal Axis Activity in Patients With Functional Gastrointestinal Disorders and Healthy Controls .Psychosomatic Medicine,2005,67 (2):288-294. PMID: 15784796 [PubMed - indexed for MEDLINE]
    [15] Flemstr?m G , Sj?blom M .Epithelial Cells and Their Neighbors. II. New perspectives on efferent signaling between brain, neuroendocrine cells, and gut epithelial cells .Am J Physiol Gastrointest Liver Physiol, 2005,289 (3): G377-G380. PMID: 16093418 [PubMed - indexed for MEDLINE]
    [16] David G.Serotonin and sensory signalling from the gastrointestinal lumen. J Physiol,2006,575 (Pt 1):1-2. PMID: 16740608 [PubMed - indexed for MEDLINE]
    [17] Yang Y, Jury Y ,Johan D,S?blom M .Chronic Psychological Stress in Rats Induces Intestinal Sensitization to Luminal Antigens. American Journal of Pathology , 2006,168 (1):104-114. PMID: 16400013 [PubMed - indexed for MEDLINE]
    [18] Tu Y, Di Leo V, Salim S, Soderholm JD, Marshall J, Irvine J. CD23/Fc epsilon RII (low affinity IgE receptor) is expressed on human epithelial cells and upregulated by IL-4 and LPS. Gastroenterology , 2001,120:A188.
    [19] Barbara G,Stanghellini V,De Giorgio R,et al.Functional gastrointestinal disorders and mast cells: implications for therapy .Neurogastroenterol Motil,2006,18 (1): 6–17. PMID: 16371078 [PubMed - indexed for MEDLINE]
    [20] Ahmed Kayssi,Silvia Amadesi,Francisco Bautista, et al.Bunnettand Stephen Vanner. Mechanisms of protease- activated receptor 2-evoked hyperexcitability of nociceptive neurons innervating the mouse colon .J Physiol,2007,580(3): 977-991. PMID: 17289784 [PubMed - indexed for MEDLINE]
    [21] Mayer EA, Naliboff BD, Chang L, et al. Stress and the Gastrointestinal Tract: V. Stress and irritable bowel syndrome . Am J Physiol Gastrointest Liver Physiol, 2001,280(4): G519–G524. PMID: 11254476 [PubMed - indexed for MEDLINE]
    [22] Andre G,Buret.How Stress Induces Intestinal Hypersensitivity .American Journal of Pathology,2006,168 (1): 3-5. PMID: 16400003 [PubMed - indexed for MEDLINE]
    [23] Spiller R,Campbell E.Post-infectious irritable bowel syndrome .Curr OpinGastroenterol, 2007,9(5):378-84. PMID: 17991338 [PubMed - indexed for MEDLINE]
    [24] Lomax AE, O'Hara JR, Hyland NP, et al .Persistent alterations to enteric neural signalling in guinea pig colon following resolution of colitis .Am J Physiol Gastrointest Liver Physiol. 2007 Feb,292(2):G482-91. PMID: 17008554 [PubMed– indexed for MEDLINE]
    [25] Woolf, CJ, and Doubell TP. The pathophysiology of chronic pain increased sensitivity to low threshold A beta-fibre inputs. Curr Opin Neurobiol, 1994, 4(4): 525-534. PMID: 7812141 [PubMed - indexed for MEDLINE]
    [26]王巍峰,杨云生,孙刚,等.肠易激综合征大鼠模型脊髓后角神经递质表达的改变[J].胃肠病学和肝病学杂志,2006,15(4):405-408.维普网
    [27] Lawal A, Kern M, Sanjeevi A, et al. Cingulate cortex: a closer look at its gut-related functional topography. Am J Physiol Gastrointest Liver Physiol ,2005, 289(4): G722-G730. PMID: 16160081 [PubMed - indexed for MEDLINE]
    [28] Duvarci S ,Nader K ,LeDoux JE .Activation of extracellular signal-regulated kinase- mitogen- activated protein kinase cascade in the amygdala is required for memory reconsolidation of auditory fear conditioning .Eur J Neurosci, 2005,21 (1):283-289. PMID: 15654867 [PubMed - indexed for MEDLINE]
    [29] Yarimar C,Robert W,Gereau IV.Activation of the Extracellular Signal- Regulated Kinase in the Amygdala Modulates Pain Perception .The Journal of Neuroscience ,2007,27(7):1543-1551. PMID: 17301163 [PubMed - indexed for MEDLINE]
    [30] Greenwood-Van Meerveld B,Gibson M,Gunter W,et al.Stereotaxic delivery of corticosterone to the amygdala modulates colonic sensitivity in rats[J].2001,893 (1-2):135-142. PMID: 11223001 [PubMed - indexed for MEDLINE]

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700